Carbohydrate 'cage' allows precise drug delivery to the gastrointestinal tract
Credit: UBC, Michael Smith Laboratories More Canadians suffer from inflammatory bowel disease (IBD) than anywhere else in the world, yet current treatments often have debilitating side effects and are not always effective. According to Crohn's and Colitis Canada, 1 in 140 Canadians lives with Crohn's or colitis, the two main forms of IBD. The disease inflames the lining of the gastrointestinal (GI) tract and disrupt the body's ability to digest food, absorb nutrition, and eliminate waste in a healthy matter. This can lead to severe abdominal pain, chronic diarrhea, and life-threatening compli...